Guardant Health
GH
39,71 €
Share price
-4.76%
Change (1 day)
139.06%
Change (1 year)
Categories
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.
Guardant Health (GH) - Net assets
Net assets on the balance sheet as of December 2024 : -€0.13 Billion
According to Guardant Health
's latest financial reports the company has -€0.13 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Guardant Health - Net assets on balance sheet (from 2017 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $-€0.14 Billion | -193.49% |
| 2023-12-31 | $€0.14 B | 155.86% |
| 2022-12-31 | $€56.1 M | -90.15% |
| 2021-12-31 | $€0.56 B | -48.32% |
| 2020-12-31 | $€1.10 B | 45.59% |
| 2019-12-31 | $€0.75 B | 64.96% |
| 2018-12-31 | $€0.45 B | 78.41% |
| 2017-12-31 | $€0.25 B | 239.46% |
| 2016-12-31 | $€75.76 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 | €1.10 B | -956.03% | 🇺🇸 USA |
 | €2.46 B | -2,011.30% | 🇺🇸 USA |